July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi-Aventis’ ...
Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
Techdow USA Inc., a division of the Hepalink Group (Techdow USA), has announced its next finished drug product launch, Enoxaparin Sodium (Enoxaparin). This product is expected to launch in June of ...
A steamy shipping glitch has forced Novartis' generics unit to yank a batch of deep vein thrombosis meds from U.S. shelves. Sandoz is recalling one lot of enoxaparin sodium injection single-dose ...
Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion ...
Enoxaparin (Lovenox) reduces the risk of blood clots in partially paralyzed stroke patients to a greater extent than unfractionated heparin, according to a large-scale multinational study. Researchers ...
LONDON (Reuters) - Bayer AG has launched its new anticoagulant pill Xarelto in Britain and Germany, pricing the product on a par with Sanofi-Aventis's Lovenox injection, the company said on Thursday.
NEW YORK/LONDON, Nov 6 (Reuters) - U.S. regulators have rejected Momenta Pharmaceuticals Inc's generic version of Sanofi-Aventis SA's top-selling thrombosis drug Lovenox, sending Momenta shares into a ...
Sandoz Canada launches its sixth biosimilar, an anticoagulant used to treat deep vein thrombosis, on the Canadian market. Sandoz Canada launched its sixth biosimilar, Inclunox (enoxaparin sodium), on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results